Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers set to get a boost in China as Opdivo aces PhIII lung cancer study early
Bristol-Myers set to get a boost in China as Opdivo aces PhIII lung cancer study early
Bristol-Myers set to get a boost in China as Opdivo aces PhIII lung cancer study early
Submitted by
admin
on December 1, 2017 - 9:32am
Source:
Endpoints
News Tags:
Bristol-Myers Squibb
Opdivo
China
Docetaxel
lung cancer
Headline:
Bristol-Myers set to get a boost in China as Opdivo aces PhIII lung cancer study early
Do Not Allow Advertisers to Use My Personal information
